SFE/SFC technology for isolating and purifying egg-derived compounds

Overview

Egg-derived proteins and bioactive peptides are valuable ingredients for food, nutrition, and health applications, but conventional purification processes can require multiple organic solvents and complicated separation steps. Ousia Labs is proposing an integrated supercritical fluid extraction (SFE) and supercritical fluid chromatography (SFC) platform that could make it easier to process egg-derived raw materials into high-value compounds.

The process is designed to combine a CO2-based extraction front-end with chromatographic purification, offering a scalable and lower-solvent route from raw material to refined ingredients. This could benefit manufacturers interested in developing egg-derived protein, peptide, or health ingredients with a more sustainable and cost-effective production process.

Technical specifications

The proposed platform consists of three core components:

• SFE front-end: removes and fractionates fats and lipids from egg-derived raw material, cleaning it for downstream separation.
• SFC purification: uses CO2-based mobile phases to separate proteins and selected smaller peptides without relying primarily on large volumes of organic solvents.
• Temperature-sensitive processing: supercritical CO2 can be used at relatively low temperatures, helping protect heat-sensitive peptides and proteins.

The development pathway is designed to move from benchtop experiments to pilot scale and eventually to mass production. This staged approach allows process conditions and economics to be refined before full industrialization.

Ousia Labs brings its existing CO2 extraction hardware expertise to the project, which provides a practical foundation for developing the SFE/SFC integration.

Technology readiness level

This technology is currently at the research and development stage for egg-derived compounds. The hypothesis and processing plan are defined, but the platform has not yet completed and validated for this specific feedstock.

The next validation steps are:

1. Benchtop proof-of-concept to confirm fractionation and purification performance.
2. Pilot-scale trials to test reproducibility, scale-up feasibility, and cost efficiency.
3. Mass-production implementation once the process is fully validated.

Until these stages are completed, the yield and purity from egg-derived materials will not be considered commercially demonstrated.